Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04710563 · ClinicalTrials.gov registry record
SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs
A clinical trial of Peripheral Arterial Disease, sponsored by Yale University.
- Active
- Registry status
- 458
- Enrollment target
- 1
- Study location
NCT04710563: Active study of Peripheral Arterial Disease, sponsored by Yale University.
NCT04710563 is a study of Peripheral Arterial Disease that is active but no longer recruiting, run by Yale University. The registered enrollment target is 458 participants, below the 4,200-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04710563, a study of Peripheral Arterial Disease, is active but no longer recruiting, sponsored by Yale University.
- ACTIVE NOT RECRUITING
- Registry status
- 458 participants
- Enrollment target
- 1
- Study location
Study Summary
A research project capturing experiences of patients with critical limb threatening ischemia, with the ultimate goal of setting new standards for diagnosing, describing detailed patient-centered outcomes, and evaluating the variability in therapeutic approaches and their association with outcomes.
Primary Outcome
PAD-specific, multi-dimensional health status instrument with a CLI specific module. Higher scores indicate better functioning.
Conditions Studied
Study Locations (1)
Connecticut
- Yale New Haven Health - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 458 participants |
| Start Date | 2021-08-11 |
| Est. Completion | 2028-09 |
What the registry record for NCT04710563 still lists
NCT04710563 is an observational study that tracks outcomes without assigning an intervention. The registered 458 participants enrollment target is mid-sized for trials with a published cap, below the 4,200-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 0 interventions.
NCT04710563 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT04710563 about?
NCT04710563 is a clinical study titled "SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs". A research project capturing experiences of patients with critical limb threatening ischemia, with the ultimate goal of setting new standards for diagnosing, describing detailed patient-centered outcomes, and evaluating the variability in therapeutic approaches and their association with outcomes.
What is the current status of trial NCT04710563?
This trial is currently active not recruiting. The enrollment target is 458 participants. The study started on 2021-08-11. Estimated completion is 2028-09.
What conditions does trial NCT04710563 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease.
Who is sponsoring clinical trial NCT04710563?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04710563 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04710563's enrollment target sits among peer trials
458 8th of 79 higher than 72 of 79 other Peripheral Arterial Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Arterial Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RECRUITING · Phase 3
-
Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
RECRUITING · Phase 4
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05856942 · 458 participants · NA
Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program
- NCT06201676 · 458 participants · Phase 4
Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients
- NCT04452825 · 459 participants · NA
A New Psychotherapy Intervention for Older Cancer Patients
- NCT02977780 · 460 participants · Phase 2
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI